LXRX
Lexicon Pharmaceuticals Inc
NASDAQ: LXRX · HEALTHCARE · BIOTECHNOLOGY
$1.61
+3.87% today
Updated 2026-04-30
Market cap
$716.02M
P/E ratio
—
P/S ratio
14.38x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$1 – $2
Volume
2.4M
Lexicon Pharmaceuticals Inc (LXRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72.80M | $50.12M | $32.32M | $10.70M | $4.91M | $1.85M | $1.09M | $2.22M | $22.85M | $130.01M | $83.34M | $90.33M | $63.21M | $322.07M | $24.00M | $298000.00 | $139000.00 | $1.20M | $31.08M | $49.80M |
| Revenue growth (YoY) | — | -31.2% | -35.5% | -66.9% | -54.1% | -62.3% | -41.1% | +104.0% | +928.5% | +468.9% | -35.9% | +8.4% | -30.0% | +409.5% | -92.5% | -98.8% | -53.4% | +766.2% | +2481.5% | +60.2% |
| Cost of revenue | $116.83M | $115.81M | $120.93M | $94.50M | $91.62M | $103.49M | $82.57M | $89.68M | $89.28M | $95.19M | $163.97M | $1.90M | $2.49M | $3.23M | $1.93M | $55.05M | $52.52M | $58.97M | $616000.00 | $274000.00 |
| Gross profit | $72.80M | $50.12M | $32.32M | $10.70M | $4.91M | $1.85M | $-81.48M | $-87.46M | $-66.42M | $34.83M | $-80.64M | $88.44M | $60.72M | $318.84M | $22.07M | $-54.75M | $-52.38M | $-57.77M | $30.46M | $49.53M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -7482.6% | -3936.1% | -290.6% | 26.8% | -96.8% | 97.9% | 96.1% | 99.0% | 92.0% | -18371.8% | -37681.3% | -4798.0% | 98.0% | 99.4% |
| R&D | $106.69M | $104.33M | $108.58M | $81.24M | $75.35M | $91.83M | $82.57M | $89.68M | $89.28M | $95.19M | $178.15M | $156.81M | $100.24M | $91.92M | $153.62M | $55.05M | $52.82M | $58.89M | $84.48M | $61.12M |
| SG&A | $21.33M | $20.74M | $20.28M | $19.42M | $22.57M | $17.35M | $17.04M | $17.12M | $19.41M | $23.84M | $43.04M | $66.20M | $63.75M | $56.84M | $47230.00 | $32.34M | $48.08M | $97.70M | $143.10M | $37.32M |
| Operating income | $-55.23M | $-74.95M | $-96.53M | $-89.96M | $-95.72M | $-114.09M | $-108.42M | $-102.37M | $-100.37M | $1.47M | $-137.16M | $-136.68M | $-103.28M | $141.44M | $-47.80M | $-87.09M | $-100.76M | $-171.75M | $-197.12M | $-48.91M |
| Operating margin | -75.9% | -149.6% | -298.7% | -840.7% | -1950.2% | -6170.6% | -9955.5% | -4607.2% | -439.2% | 1.1% | -164.6% | -151.3% | -163.4% | 43.9% | -199.2% | -29224.8% | -72489.2% | -14265.0% | -634.2% | -98.2% |
| EBITDA | $-39.98M | $-64.53M | $-86.26M | $-84.29M | $-93.69M | $-108.80M | $-103.91M | $-99.29M | $-96.18M | $11.72M | $-125.82M | $-125.27M | $-96.09M | $148.45M | $-41.10M | $-86.80M | $-100.03M | $-169.76M | $-184.29M | $-48.29M |
| EBITDA margin | -54.9% | -128.8% | -266.9% | -787.8% | -1908.9% | -5884.3% | -9541.5% | -4468.6% | -420.9% | 9.0% | -151.0% | -138.7% | -152.0% | 46.1% | -171.3% | -29126.8% | -71966.2% | -14099.3% | -592.9% | -97.0% |
| EBIT | $-51.18M | $-74.95M | $-96.33M | $-90.45M | $-99.08M | $-113.69M | $-108.10M | $-102.16M | $-98.11M | $10.99M | $-127.87M | $-128.67M | $-99.77M | $144.79M | $-44.03M | $-87.09M | $-100.46M | $-170.31M | $-184.82M | $-48.91M |
| Interest expense | $3.25M | $2.77M | $2.69M | $2.97M | $2.72M | $2.53M | $2.11M | $1.97M | $2.25M | $6.72M | $6.57M | $6.98M | $20.78M | $20.68M | $14.54M | $802000.00 | $2.78M | $13.10M | $15.58M | $8.34M |
| Income tax | $-119000.00 | $-16.16M | $-19.68M | $-102000.00 | $-26000.00 | $-2.36M | $-1.97M | $-833000.00 | $-70000.00 | $6.00M | $4.51M | $-12.66M | $3.51M | $-6.01M | $11.61M | $510000.00 | $1.18M | $386105.00 | $-200.40M | — |
| Effective tax rate | 0.2% | 21.6% | 20.4% | 0.1% | 0.0% | 2.0% | 1.8% | 0.8% | 0.1% | 456.6% | -3.3% | 8.9% | -3.0% | -4.8% | -24.7% | -0.6% | -1.2% | -0.2% | 50.0% | 0.0% |
| Net income | $-54.31M | $-58.79M | $-76.86M | $-82.78M | $-101.78M | $-116.22M | $-110.21M | $-104.13M | $-100.29M | $-4.68M | $-141.43M | $-129.05M | $-120.55M | $130.13M | $-58.57M | $-87.76M | $-101.94M | $-177.12M | $-200.40M | $-50.34M |
| Net income growth (YoY) | — | -8.3% | -30.7% | -7.7% | -22.9% | -14.2% | +5.2% | +5.5% | +3.7% | +95.3% | -2920.7% | +8.8% | +6.6% | +208.0% | -145.0% | -49.8% | -16.2% | -73.7% | -13.1% | +74.9% |
| Profit margin | -74.6% | -117.3% | -237.8% | -773.6% | -2073.7% | -6285.3% | -10120.4% | -4686.1% | -438.8% | -3.6% | -169.7% | -142.9% | -190.7% | 40.4% | -244.1% | -29449.0% | -73341.0% | -14710.9% | -644.8% | -101.1% |